Cardionomic President and CEO
Steve Goedeke’s extensive experience spans implantable defibrillators, pacemakers, therapies for heart failure, device design, and wireless communications.
Before joining Cardionomic as President and CEO, Goedeke was President and CEO at Denali Medical II and previously served as a Senior Director within Medtronic’s Cardiac Rhythm Disease Management division. He is a Bakken Fellow and was largely responsible for the creation of the MICS wireless system. He is also a two-time recipient of Medtronic’s Star of Excellence and was granted The Chairman’s Award for Outstanding Initiative. Before his 17 years at Medtronic, Goedeke held various technical and business development roles at Hewlett-Packard.
Goedeke is a named inventor on 25 patents and holds a B.S in electrical engineering from Washington University in St. Louis and a M.S. in electrical engineering from the University of Illinois at Urbana-Champaign.
William Abraham, M.D., F.A.C.P., F.A.C.C., F.A.H.A., F.E.S.C., F.R.C.P.E
Scientific Advisory Board Chair
Dr. William Abraham’s research interests include hemodynamic and neurohormonal mechanisms in heart failure, sleep disordered breathing in heart failure, and clinical drug and device trials in heart failure and cardiac transplantation. Dr. Abraham has participated in all regulatory phases of new drug and device development from pre-clinical evaluation to Pre-Market Approval (PMA) and New Drug Application (NDA) submission and approval.
In addition to his role as Scientific Advisor for Cardionomic, Dr. Abraham also serves as Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine at Ohio State University College of Medicine. He previously held faculty appointments at the University of Colorado, the University of Cincinnati, and the University of Kentucky. Dr. Abraham earned his medical degree from Harvard Medical School, and after that he completed his residency in Internal Medicine and fellowships in Cardiovascular Disease and Advanced Heart Failure and Transplant Cardiology at the University of Colorado Health Sciences Center. Board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure and Transplant Cardiology, he spends the majority of his clinical time managing heart failure patients in the inpatient and outpatient settings.
Dr. Abraham is the author of more than 700 original papers, abstracts, book chapters, and review articles. He has also co-authored national heart failure practice guidelines and co-edited Heart Failure: A Practical Approach to Treatment, a leading textbook on heart failure. He continues to serve on the editorial boards of several major journals.
Senior Vice President of Product Development
Todd Kerkow has in-depth knowledge of the medical device product development process, including concept development, prototype creation, manufacturing process development, design verification, clinical validation, global commercial launch, high volume production, and the regulatory steps along the way. He has a proven track record in leading teams that successfully deliver medical devices that address unmet needs and are meaningful for patients, physicians, employees, and investors. Todd has 22 years of product development experience with continually increasing levels of engineering, management and leadership responsibilities.
Before joining Cardionomic, Todd was Vice President of Product Development at Microchips Biotech, a developer of an active implantable drug delivery device. Prior to that, he was Director of Program Management at Boston Scientific, where he led pacemaker and defibrillator development teams. Prior to Boston Scientific, Todd was Vice President of Product Development at Cameron Health, the developer of the worlds first subcutaneous implantable defibrillator. Prior to Cameron Health, Todd held various management and engineering positions at Guidant corporation’s Cardiac Rhythm Management division.
Todd has his B.S. and M.S. in Mechanical Engineering from the University of Minnesota.
Clinical and Research Director
Michelle Kennefick has 19 years of experience in clinical research spanning setting strategy through execution. Prior to Cardionomic, Michelle served as Clinical Strategy Director for the Men’s Health at Boston Scientific where she was responsible for the Physician Education and Training Program as well as pre-and post-market studies. Michelle also served on the remediation team addressing regulatory requirements related to risk and harm documentation. At Medtronic, Michelle led the team responsible for early research studies on cardiac rhythm technologies as well as devices for heart failure diagnostics and therapies. Additionally, Michelle managed multiple global clinical programs on various heart failure technologies from early concept to market approval. While at Medtronic, Michelle also participated on many clinical and quality functional initiatives, was selected for the Leadership Acceleration Program and twice received Star of Excellence awards.
Michelle received her Certificate of Health Economics and Outcomes Research from the University of Washington, a Master in Public Health with a major in Epidemiology from the University of Minnesota, and a B.A. from St. Thomas University with a major in Mathematics and Biology and a minor in Chemistry.
CAUTION: INVESTIGATIONAL DEVICE LIMITED BY FEDERAL (UNITED STATES) LAW TO INVESTIGATIONAL USE.
©2016 Cardionomic, Inc. All Rights Reserved.